October 19, 2026

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

Tempus: Study presented at ESMO evaluated more than 60,000 advanced NSCLC cases and found greater than 80% sensitivity across all 12 biomarkers using routine H&E pathology images CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today...

recent articles

WEBINAR – THURSDAY, OCTOBER 24TH 11 am CEST – SAVE YOUR SEAT 10 am PDT | 1 pm EDT – SAVE YOUR SEAT Join Visiopharm Thursday, 24th of October for a peek at the new image analysis algorithm that will simplify your workflow and...

Mumbai/Misgav/North Carolina — Life sciences Artificial Intelligence products and services company, AIRA Matrix (“AIRA Matrix”), and microscope-based digital pathology platform Augmentiqs (“Augmentiqs”), announced the world’s first...

by: Amy Baxter Stanford researchers have developed an AI tool that can help diagnose damaging brain aneurysms that can have potentially fatal effects. The development of the tool was detailed in a...

San Jose, CA, September 17th, 2019: OptraSCAN®, the leading On-Demand Digital Pathology solution provider today announced that Dr. Manu Sebastian, Associate Professor & Director - The University of Texas MD Anderson Cancer Center (MDACC)...

Two decades ago, an engineer named Dirk Soenksen started a small company he named Aperio (Latin for reveal) that would one day make significant contributions to the field of diagnostics. Today, this Vista-based company is a pioneer in digital...

Inspirata and IBEX Medical Analytics Announce New Technical Partnership at the European Congress of Pathology (ECP) Enabling Joint Customers to Utilize Artificial Intelligence-Based Image Analysis to Reduce Cancer Case Turnaround Time and...

OR

platinum partners

gold partners

Silver Partners

Media Partners